Page last updated: 2024-12-10

goitrin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

goitrin: RN given refers to cpd with unspecified isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

(R)-goitrin : A 5-ethenyl-1,3-oxazolidine-2-thione that has R-configuration. It is a constituent of a traditional Chinese herbal medicine, Radix isatidis. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID3032313
CHEMBL ID442589
CHEBI ID183228
SCHEMBL ID3500968
MeSH IDM0045359

Synonyms (41)

Synonym
(5r)-5-ethenyl-1,3-oxazolidine-2-thione
1072-93-1
CHEBI:183228
(5r)-5-vinyl-1,3-oxazolidine-2-thione
(r)-5-vinyl-2-oxazolidinethione
2-oxazolidinethione, 5-ethenyl-, (r)-
r-5-vinyl-2-oxazolidinethione
ba 51-090278
ai3-52770
d-goitrin
(r)-5-ethenyl-2-oxazolidinethione
(r)-goitrin
2-oxazolidinethione, 5-vinyl-, (r)-
epigoitrin
c5h7nos
goitrin
CHEMBL442589
AKOS006276218
2n815d740r ,
unii-2n815d740r
S9078
goitrin, d-
2-oxazolidinethione, 5-ethenyl-, (5r)-
(r)-5-vinyloxazolidine-2-thione
(+)-5-vinyl-2-oxazolidinethione
epi-goitrin
goitrin, (+)-
SCHEMBL3500968
Q-100044
ba-51-090278
goitrine
epigotrin
mfcd01709801
ethyl-p-methoxycinnamate
ZB1854
CCG-266110
Q27255092
HY-N0224
CS-0008262
DTXSID501318342
epigoitrin (optically pure)

Research Excerpts

Overview

Goitrin is a moderate inhibitor of purified bovine adrenal dopamine beta-hydroxylase. It has been shown to induce glutathione S-transferase activity and to increase aflatoxin detoxification.

ExcerptReferenceRelevance
"Goitrin is a moderate inhibitor of purified bovine adrenal dopamine beta-hydroxylase."( Inhibition of dopamine beta-hydroxylase by goitrin, a natural antithyroid compound.
Hubbard, LS; Wright, J; Zenker, N,
)
1.12
"Goitrin is a potent goitrogen that has been shown to induce glutathione S-transferase (GST) activity and to increase aflatoxin detoxification. "( Modulation of glutathione S-transferase activity and isozyme pattern in liver and small intestine of rats fed goitrin- and T3-supplemented diets.
Bjeldanes, LF; Kelley, MK, 1995
)
1.95

Treatment

ExcerptReferenceRelevance
"R-goitrin treatment increased the relative thyroid weight, more in male rats than in females."( Hepatic effects of R-goitrin in Sprague-Dawley rats.
Daxenbichler, E; Nishie, K, 1982
)
1.14

Pharmacokinetics

ExcerptReferenceRelevance
", responsible for antiviral antiendotoxin activity; however, few pharmacokinetic studies have been conducted."( Metabolic profiles and pharmacokinetics of goitrin in rats through liquid chromatography combined with electrospray ionization-tandem mass spectrometry.
Han, H; Li, J; Shi, Y; Wang, R; Wang, Z; Xu, Y; Yang, L, 2019
)
0.78

Dosage Studied

ExcerptRelevanceReference
"The effects of pressure, temperature, time, concentration and dosage of alcohol were studied by single factor analysis and orthogonal test."( [The extraction technology of epigoitri from isatidis radix by supercritical CO2 fluid].
Liu, CY; Liu, LM; Nian, SH; Yang, LF, 2013
)
0.39
"The optimized conditions were as follows: The pressure was 20 MPs, the temperature was 50 degrees C, the time was 2 h, concentration of alcohol was 100%, dosage was 80 mL."( [The extraction technology of epigoitri from isatidis radix by supercritical CO2 fluid].
Liu, CY; Liu, LM; Nian, SH; Yang, LF, 2013
)
0.39
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
antiviral agentA substance that destroys or inhibits replication of viruses.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
5-ethenyl-1,3-oxazolidine-2-thioneA member of the class of oxazolidines that is 1,3-oxazolidine substituted by sulfanylidene and ethenyl groups at positions 2 and 5, respectively.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (8)

Assay IDTitleYearJournalArticle
AID1101240Antigerminative activity against Lactuca sativa (lettuce) seeds up to 16 mM after 7 days relative to control2001Journal of agricultural and food chemistry, Jan, Volume: 49, Issue:1
Preparation and biological activity of four epiprogoitrin myrosinase-derived products.
AID339041Inhibition of bovine adrenal dopamine beta-hydroxylase assessed as norepinephrine formation per mg of protein at 0.1 mM after 45 mins
AID1101246Toxicity against Lactuca sativa (lettuce) assessed as decrease in root hair at 24 to 32 mM after 7 days2001Journal of agricultural and food chemistry, Jan, Volume: 49, Issue:1
Preparation and biological activity of four epiprogoitrin myrosinase-derived products.
AID1101252Toxicity against Lactuca sativa (lettuce) assessed as Inhibition of root growth at 4 mM after 7 days relative to control2001Journal of agricultural and food chemistry, Jan, Volume: 49, Issue:1
Preparation and biological activity of four epiprogoitrin myrosinase-derived products.
AID1101245Toxicity against Lactuca sativa (lettuce) assessed as root tissue rotting at 32 mM after 7 days2001Journal of agricultural and food chemistry, Jan, Volume: 49, Issue:1
Preparation and biological activity of four epiprogoitrin myrosinase-derived products.
AID1101251Toxicity against Lactuca sativa (lettuce) assessed as Inhibition of root growth at 8 to 32 mM after 7 days relative to control2001Journal of agricultural and food chemistry, Jan, Volume: 49, Issue:1
Preparation and biological activity of four epiprogoitrin myrosinase-derived products.
AID1101239Antigerminative activity against Lactuca sativa (lettuce) seeds at 24 to 32 mM after 7 days relative to control2001Journal of agricultural and food chemistry, Jan, Volume: 49, Issue:1
Preparation and biological activity of four epiprogoitrin myrosinase-derived products.
AID1101247Toxicity against Lactuca sativa (lettuce) assessed as branched root formation at low concentration after 7 days2001Journal of agricultural and food chemistry, Jan, Volume: 49, Issue:1
Preparation and biological activity of four epiprogoitrin myrosinase-derived products.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (46)

TimeframeStudies, This Drug (%)All Drugs %
pre-199018 (39.13)18.7374
1990's6 (13.04)18.2507
2000's3 (6.52)29.6817
2010's15 (32.61)24.3611
2020's4 (8.70)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 36.53

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index36.53 (24.57)
Research Supply Index3.87 (2.92)
Research Growth Index4.98 (4.65)
Search Engine Demand Index47.86 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (36.53)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.13%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other46 (97.87%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]